vs

Side-by-side financial comparison of CXApp Inc. (CXAI) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.0M, roughly 1.7× CXApp Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -544.1%, a 393.6% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -38.5%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-3.6M). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -25.0%).

CXApp Inc. is a technology firm specializing in digital workplace experience solutions. It offers cloud-based software tools for employee engagement, office space optimization, visitor management, and hybrid work coordination, serving mid-to-large enterprises across North America, APAC and Europe.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

CXAI vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.7× larger
IVF
$1.8M
$1.0M
CXAI
Growing faster (revenue YoY)
IVF
IVF
+61.1% gap
IVF
22.6%
-38.5%
CXAI
Higher net margin
IVF
IVF
393.6% more per $
IVF
-150.5%
-544.1%
CXAI
More free cash flow
IVF
IVF
$1.8M more FCF
IVF
$-1.8M
$-3.6M
CXAI
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-25.0%
CXAI

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CXAI
CXAI
IVF
IVF
Revenue
$1.0M
$1.8M
Net Profit
$-5.6M
$-2.6M
Gross Margin
86.9%
Operating Margin
-576.9%
-93.1%
Net Margin
-544.1%
-150.5%
Revenue YoY
-38.5%
22.6%
Net Profit YoY
-56.7%
-62.2%
EPS (diluted)
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXAI
CXAI
IVF
IVF
Q4 25
$1.0M
Q3 25
$1.1M
$1.8M
Q2 25
$1.2M
$1.9M
Q1 25
$1.2M
$1.6M
Q4 24
$1.7M
$1.7M
Q3 24
$1.9M
$1.4M
Q2 24
$1.8M
$1.8M
Q1 24
$1.8M
$1.6M
Net Profit
CXAI
CXAI
IVF
IVF
Q4 25
$-5.6M
Q3 25
$-3.2M
$-2.6M
Q2 25
$-3.1M
$-5.3M
Q1 25
$-1.6M
$-17.4M
Q4 24
$-3.5M
$-3.6M
Q3 24
$-5.4M
$-1.6M
Q2 24
$-5.3M
$-2.2M
Q1 24
$-5.2M
$-1.6M
Gross Margin
CXAI
CXAI
IVF
IVF
Q4 25
86.9%
Q3 25
89.0%
Q2 25
86.0%
Q1 25
87.7%
35.2%
Q4 24
86.0%
41.4%
Q3 24
80.4%
31.0%
Q2 24
80.0%
53.1%
Q1 24
82.0%
45.3%
Operating Margin
CXAI
CXAI
IVF
IVF
Q4 25
-576.9%
Q3 25
-343.4%
-93.1%
Q2 25
-336.1%
-160.4%
Q1 25
-306.0%
-1042.1%
Q4 24
-169.7%
-202.0%
Q3 24
-194.3%
-90.7%
Q2 24
-206.7%
-100.9%
Q1 24
-197.3%
-95.7%
Net Margin
CXAI
CXAI
IVF
IVF
Q4 25
-544.1%
Q3 25
-283.4%
-150.5%
Q2 25
-256.7%
-283.6%
Q1 25
-132.0%
-1060.1%
Q4 24
-213.6%
-211.3%
Q3 24
-286.5%
-113.8%
Q2 24
-297.6%
-122.2%
Q1 24
-284.4%
-101.3%
EPS (diluted)
CXAI
CXAI
IVF
IVF
Q4 25
Q3 25
$-0.77
Q2 25
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXAI
CXAI
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$11.1M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$14.0M
$5.8M
Total Assets
$32.4M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXAI
CXAI
IVF
IVF
Q4 25
$11.1M
Q3 25
$5.1M
Q2 25
$4.9M
Q1 25
$3.9M
Q4 24
$4.9M
Q3 24
Q2 24
Q1 24
Total Debt
CXAI
CXAI
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CXAI
CXAI
IVF
IVF
Q4 25
$14.0M
Q3 25
$15.2M
$5.8M
Q2 25
$14.3M
$2.6M
Q1 25
$15.6M
$3.3M
Q4 24
$15.6M
$12.7M
Q3 24
$13.6M
$-23.3K
Q2 24
$16.3M
$1.4M
Q1 24
$20.9M
$10.2K
Total Assets
CXAI
CXAI
IVF
IVF
Q4 25
$32.4M
Q3 25
$28.5M
$18.8M
Q2 25
$29.6M
$19.3M
Q1 25
$29.3M
$31.7M
Q4 24
$31.8M
$46.4M
Q3 24
$17.0M
Q2 24
$17.8M
Q1 24
$17.3M
Debt / Equity
CXAI
CXAI
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXAI
CXAI
IVF
IVF
Operating Cash FlowLast quarter
$-3.6M
$-1.8M
Free Cash FlowOCF − Capex
$-3.6M
$-1.8M
FCF MarginFCF / Revenue
-355.5%
-101.6%
Capex IntensityCapex / Revenue
0.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-10.4M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXAI
CXAI
IVF
IVF
Q4 25
$-3.6M
Q3 25
$-2.8M
$-1.8M
Q2 25
$-3.0M
$-1.7M
Q1 25
$-979.0K
$-3.5M
Q4 24
$-2.7M
$-617.4K
Q3 24
$-2.1M
$-640.8K
Q2 24
$-1.9M
$-1.5M
Q1 24
$-650.0K
$-260.6K
Free Cash Flow
CXAI
CXAI
IVF
IVF
Q4 25
$-3.6M
Q3 25
$-2.8M
$-1.8M
Q2 25
$-3.0M
$-1.7M
Q1 25
$-984.0K
$-3.6M
Q4 24
$-696.3K
Q3 24
$-2.1M
Q2 24
$-1.9M
$-1.5M
Q1 24
$-668.0K
$-310.3K
FCF Margin
CXAI
CXAI
IVF
IVF
Q4 25
-355.5%
Q3 25
-248.1%
-101.6%
Q2 25
-247.2%
-92.6%
Q1 25
-80.4%
-216.9%
Q4 24
-40.6%
Q3 24
-109.3%
Q2 24
-108.6%
-82.3%
Q1 24
-36.7%
-19.7%
Capex Intensity
CXAI
CXAI
IVF
IVF
Q4 25
0.2%
Q3 25
0.4%
0.5%
Q2 25
0.9%
0.5%
Q1 25
0.4%
0.9%
Q4 24
0.0%
4.6%
Q3 24
0.2%
0.0%
Q2 24
0.5%
3.0%
Q1 24
1.0%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons